Venus Remedies Secures EU GMP Renewal from Infarmed, Strengthens Hold on European Market

Venus Remedies achieves the EU GMP renewal from Infarmed, underscoring its precision-driven manufacturing practices. This achievement boosts its advancement in Europe, paving the way for wider market integration and competitive edge throughout the region.

Venus Remedies Secures EU GMP Renewal from Infarmed, Strengthens Hold on European Market
Market Authorization

Venus Remedies continues its exponential growth across the globe. We are proud that as the company expands its foothold in new countries, it is also strengthening its position in the present markets. 

The renewal of the EU GMP by Infarmed highlights its strategy and commitment to maintain quality standards and excel in healthcare products.

The Growth Prospect

This renewal covers its products - Cephalosporin, Carbapenem, and oncology (Liquid and Lyophilized Injectable) formulations. Venus Remedies has already established itself as a leader in AMR and generic medicines. So, this will be vital to the company’s growth as the antibiotic market in Europe is predicted to reach USD 36.95 billion this year.

This also places Venus Remedies in the right position to emerge as a global leader in this space.

From the Director’s Desk:

The growth of Venus Remedies is led by its board of Directors with an in-depth industry understanding and experience. They work tirelessly to meet global healthcare needs and raise health standards by making high-quality products widely accessible.

"Since our first EU GMP certification in 2007, we have not only maintained but strengthened our foothold in the European market. This latest certification renewal enables us to leverage our established presence and continue our expansion into new markets," said Saransh Chaudhary, president of Global Critical Care, Venus Remedies, and CEO of Venus Medicine Research Centre. 

Aditi Chaudhary, president of International Business at Venus Remedies, emphasized the strategic importance of this renewal.

"This EU-GMP certification is pivotal, ensuring that Venus Remedies continues to provide dependable and effective healthcare solutions across Europe. It positions us to expand our reach not just within the EU, but also into Rest of World (ROW) markets, capitalizing on emerging opportunities and fostering growth in regions that demand high-quality products," said Chaudhary.

Continuing the Legacy

Venus Remedies has an impressive list of accolades to its credit. As the team continues to enhance its quality standards, the company is set to grow and expand its user base. This renewal highlights the accomplishment of its strategies that are improving the global health standards and contributing to the growth of the company.

image image image image image